Ironwood Pharmaceuticals (IRWD) Stock Performance

  • Closing price: $3.55 per share as of 10:41 AM Central Europe, Thursday 22 Oct 2026.
  • Daily change: down 2.2 % over the 24‑hour period.
  • Total shares outstanding: 165.2 million.
  • Market capitalization: $599.8 million.
  • Trading volume (last 24 h): $5.4 million.
  • Performance since previous month‑end: down 21.63 %.
  • 200‑day simple moving average: $4.01.
  • 52‑week range:
  • High: $5.78 on 01 Feb 2026.
  • Low: $1.47 on 30 Oct 2025.
TickerRecent changeCurrent priceMarket cap
SANA–0.42 %$2.35$706.5 million
BXBL0 %$2.81$710.2 million
CTKB+3 %$5.50$714.9 million
OXLC–1.78 %$7.16$711.9 million
AOSL+3.47 %$23.83$705.7 million

Company Overview

Ironwood Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. The firm focuses on the discovery, development, manufacturing, and commercialization of pharmaceutical products. Its pipeline includes drugs targeting cholesterol, gastrointestinal disorders, cardiovascular diseases, pain, inflammation, and other conditions. Additional information about the company’s products and research can be found at www.ironwoodpharma.com . Ironwood’s common stock is listed on the Nasdaq stock exchange.